(NASDAQ: GDRX) Goodrx Holdings's forecast annual revenue growth rate of 14.31% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 19.9%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.31%.
Goodrx Holdings's revenue in 2023 is $766,554,000.On average, 7 Wall Street analysts forecast GDRX's revenue for 2023 to be $348,371,456,808, with the lowest GDRX revenue forecast at $334,393,406,883, and the highest GDRX revenue forecast at $362,075,980,799.
In 2024, GDRX is forecast to generate $413,067,099,073 in revenue, with the lowest revenue forecast at $385,719,276,373 and the highest revenue forecast at $434,564,329,244.